News

Mr Cline comes to Cato Research from Etrials Worldwide, where he most recently served as president and CEO. Mr Cline has over 25 years experience in the pharmaceutical

Preliminary results from the Phase III clinical trial conducted by Wyeth showed that treatment did not achieve the primary end point of the study – a reduction in

Loxonin tape is claimed to be the first loxoprofen sodium adhesive tape in Japan containing the same constituents as Loxonin pills and Loxonin powder. The adhesive tape is

After 90 days, subjects treated with a therapeutic dose of NX-1207 had a mean percentage reduction in nocturia symptom score of 41% versus 4% for subjects treated with

In the non-approvable letter, the FDA has requested safety data from additional clinical studies to address concerns over the safety of Injectafer in this population, specifically the mortality

The study globally known as Pathway, is a double-blinded, placebo-controlled study that has been designed to establish the efficacy and safety of PI-88 in the post resection liver

This recommendation is based on the data safety monitoring board’s (DSMB) review of the blinded data from the first two-thirds of the 830 patients to be enrolled in

The product is a topical corticosteroid indicated for the treatment of moderate to severe dermatosis of the scalp. As the first filer, Perrigo will be eligible for 180

Ubiquinol is the active antioxidant form of Coenzyme Q10 (CoQ10). In the first clinical trial evaluating ubiquinol effects on late-stage congestive heart failure, researchers found that critically ill